Evaluation of Therapeutic Efficacy and Safety of Tranexamic Acid Local Infiltration in Combination with Topical 4% Hydroquinone Cream Compared to Topical 4% Hydroquinone Cream Alone in Patients with Melasma: A Split-Face Study

Introduction. Melasma is an acquired pigmentary disorder characterized by hyperpigmented macules and/or patches affecting sun-exposed skin. Tranexamic acid (TA) can reduce melanin content of epidermis. Thus, we conducted this study to evaluate the efficacy and safety of tranexamic acid local infiltr...

Full description

Saved in:
Bibliographic Details
Main Authors: Zohreh Tehranchinia, Bita Saghi, Hoda Rahimi
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Dermatology Research and Practice
Online Access:http://dx.doi.org/10.1155/2018/8350317
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832545714525175808
author Zohreh Tehranchinia
Bita Saghi
Hoda Rahimi
author_facet Zohreh Tehranchinia
Bita Saghi
Hoda Rahimi
author_sort Zohreh Tehranchinia
collection DOAJ
description Introduction. Melasma is an acquired pigmentary disorder characterized by hyperpigmented macules and/or patches affecting sun-exposed skin. Tranexamic acid (TA) can reduce melanin content of epidermis. Thus, we conducted this study to evaluate the efficacy and safety of tranexamic acid local infiltration in combination with topical 4% hydroquinone cream compared to topical 4% hydroquinone cream alone in patients with melasma. Material and Methods. This study was a prospective assessor- and analyst-blind, randomized split-face clinical trial which was performed on patients with bilateral malar epidermal melasma. A total of 55 patients were enrolled, and each side of their face was randomly allocated to either TA+HQ or HQ alone treatment. The MASI score was applied as an objective measurement to compare two treatment groups. The patient's satisfaction of melasma treatment was evaluated using a four-scale grading, as well. Results. The mean of MASI score in week 16 decreased in both groups significantly (p < 0.01). The therapeutic outcomes were significantly better in TA+HQ group than HQ group (p=0.001). Patients satisfaction with treatment was significantly higher in the TA + HQ group. The difference between the two groups regarding side effect occurrence was not statistically significant. Conclusion. Addition of tranexamic acid injections to conventional hydroquinone therapy can increase the efficacy of topical treatment. This trial is registered with IRCT2015110324865N1.
format Article
id doaj-art-684191b51e714b7c958b1634bca82576
institution Kabale University
issn 1687-6105
1687-6113
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Dermatology Research and Practice
spelling doaj-art-684191b51e714b7c958b1634bca825762025-02-03T07:25:01ZengWileyDermatology Research and Practice1687-61051687-61132018-01-01201810.1155/2018/83503178350317Evaluation of Therapeutic Efficacy and Safety of Tranexamic Acid Local Infiltration in Combination with Topical 4% Hydroquinone Cream Compared to Topical 4% Hydroquinone Cream Alone in Patients with Melasma: A Split-Face StudyZohreh Tehranchinia0Bita Saghi1Hoda Rahimi2Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IranSkin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IranSkin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IranIntroduction. Melasma is an acquired pigmentary disorder characterized by hyperpigmented macules and/or patches affecting sun-exposed skin. Tranexamic acid (TA) can reduce melanin content of epidermis. Thus, we conducted this study to evaluate the efficacy and safety of tranexamic acid local infiltration in combination with topical 4% hydroquinone cream compared to topical 4% hydroquinone cream alone in patients with melasma. Material and Methods. This study was a prospective assessor- and analyst-blind, randomized split-face clinical trial which was performed on patients with bilateral malar epidermal melasma. A total of 55 patients were enrolled, and each side of their face was randomly allocated to either TA+HQ or HQ alone treatment. The MASI score was applied as an objective measurement to compare two treatment groups. The patient's satisfaction of melasma treatment was evaluated using a four-scale grading, as well. Results. The mean of MASI score in week 16 decreased in both groups significantly (p < 0.01). The therapeutic outcomes were significantly better in TA+HQ group than HQ group (p=0.001). Patients satisfaction with treatment was significantly higher in the TA + HQ group. The difference between the two groups regarding side effect occurrence was not statistically significant. Conclusion. Addition of tranexamic acid injections to conventional hydroquinone therapy can increase the efficacy of topical treatment. This trial is registered with IRCT2015110324865N1.http://dx.doi.org/10.1155/2018/8350317
spellingShingle Zohreh Tehranchinia
Bita Saghi
Hoda Rahimi
Evaluation of Therapeutic Efficacy and Safety of Tranexamic Acid Local Infiltration in Combination with Topical 4% Hydroquinone Cream Compared to Topical 4% Hydroquinone Cream Alone in Patients with Melasma: A Split-Face Study
Dermatology Research and Practice
title Evaluation of Therapeutic Efficacy and Safety of Tranexamic Acid Local Infiltration in Combination with Topical 4% Hydroquinone Cream Compared to Topical 4% Hydroquinone Cream Alone in Patients with Melasma: A Split-Face Study
title_full Evaluation of Therapeutic Efficacy and Safety of Tranexamic Acid Local Infiltration in Combination with Topical 4% Hydroquinone Cream Compared to Topical 4% Hydroquinone Cream Alone in Patients with Melasma: A Split-Face Study
title_fullStr Evaluation of Therapeutic Efficacy and Safety of Tranexamic Acid Local Infiltration in Combination with Topical 4% Hydroquinone Cream Compared to Topical 4% Hydroquinone Cream Alone in Patients with Melasma: A Split-Face Study
title_full_unstemmed Evaluation of Therapeutic Efficacy and Safety of Tranexamic Acid Local Infiltration in Combination with Topical 4% Hydroquinone Cream Compared to Topical 4% Hydroquinone Cream Alone in Patients with Melasma: A Split-Face Study
title_short Evaluation of Therapeutic Efficacy and Safety of Tranexamic Acid Local Infiltration in Combination with Topical 4% Hydroquinone Cream Compared to Topical 4% Hydroquinone Cream Alone in Patients with Melasma: A Split-Face Study
title_sort evaluation of therapeutic efficacy and safety of tranexamic acid local infiltration in combination with topical 4 hydroquinone cream compared to topical 4 hydroquinone cream alone in patients with melasma a split face study
url http://dx.doi.org/10.1155/2018/8350317
work_keys_str_mv AT zohrehtehranchinia evaluationoftherapeuticefficacyandsafetyoftranexamicacidlocalinfiltrationincombinationwithtopical4hydroquinonecreamcomparedtotopical4hydroquinonecreamaloneinpatientswithmelasmaasplitfacestudy
AT bitasaghi evaluationoftherapeuticefficacyandsafetyoftranexamicacidlocalinfiltrationincombinationwithtopical4hydroquinonecreamcomparedtotopical4hydroquinonecreamaloneinpatientswithmelasmaasplitfacestudy
AT hodarahimi evaluationoftherapeuticefficacyandsafetyoftranexamicacidlocalinfiltrationincombinationwithtopical4hydroquinonecreamcomparedtotopical4hydroquinonecreamaloneinpatientswithmelasmaasplitfacestudy